Related Experiment Video
Updated: Apr 21, 2026
10:58
Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR qPCR Arrays
Published on: December 3, 2010
16.7K
Prognostic biomarkers for HNSCC using quantitative real-time PCR and microarray analysis: β-tubulin isotypes and the
Sharon Lobert1, Mary E Graichen, Robert D Hamilton
1School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi.
Cytoskeleton (Hoboken, N.J.)
|October 31, 2014
Summary
Head and neck squamous cell cancer (HNSCC) research identifies beta-tubulin expression as a potential prognostic biomarker. Understanding its patterns may lead to improved therapies and patient survival for HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Head and neck squamous cell cancer (HNSCC) affects over 40,000 individuals annually in the US, with limited knowledge of molecular targets for improved therapies.
- Current treatments incorporate taxanes, which target beta-tubulin, a key protein in microtubule formation and cell division.
Purpose of the Study:
- To explore the potential of beta-tubulin expression patterns as prognostic biomarkers in HNSCC.
- To identify novel therapeutic targets for HNSCC by investigating the role of beta-tubulin isotypes, p53, and micro-RNAs.
Main Methods:
- Analysis of beta-tubulin expression patterns in HNSCC.
- Investigation of the correlation between beta-tubulin expression, p53 activity, and micro-RNA profiles.
- Review of laboratory and clinical data linking tubulin expression to patient survival.
Main Results:
- Laboratory and clinical research suggests a link between beta-tubulin expression and HNSCC patient survival.
- Patterns of beta-tubulin isotype expression may serve as useful prognostic indicators.
Conclusions:
- Beta-tubulin expression patterns, alongside p53 and micro-RNA activity, could be valuable prognostic biomarkers for HNSCC.
- These molecular markers may also suggest potential therapeutic targets for enhancing patient outcomes in HNSCC.
